Glenmark Share Price May Rise – Is Your Debt Strategy Ready?
Glenmark Share Price: A historic $1.925 billion licensing agreement for Glenmark Pharmaceuticals’ cancer medication ISB 2001, which was revealed on July 10, 2025, has excited investors. As of July 11, 2025, the stock was trading at roughly ₹2,094.40, up 10.01% from its last closing, indicating excitement over the deal’s potential to increase income [Moneycontrol]. This … Read more